SCHEMBL7252456

SCHEMBL7252456

Clc1cccc2[nH]c(C[AsH2])nc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 1/20 0.51
▸ ADORA1 P30542 2/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ MAOB P27338 1/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ ADORA2B P29275 1/20 0.42
▸ NUDT1 P36639 1/20 0.41
▸ MGAM O43451 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ SI P14410 1/20 0.40
▸ MGAM2 Q2M2H8 1/20 0.40
▸ EGLN1 Q9GZT9 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LCK P06239 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307747 0.84 PSMB8 (0.53) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL1918622 0.82 DDAH1 (0.53) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL5738314 0.82 PSMB8 (0.51) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL1917492 0.79 PSMB8 (0.49) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL11574137 0.78 PSMB8 (0.59) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL1917800 0.78 PSMB8 (0.47) PSMB8
SCHEMBL38661181 0.77 ADORA1 (0.51) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL7608595 0.76 PSMB8 (0.45) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL2845899 0.76 POLB (0.46) PSMB8ADORA1ADORA3MAOBADORA2A
SCHEMBL66295 0.75 PSMB8 (0.59) PSMB8ADORA1ADORA3MAOBADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030013724-A1 Novel prolines as antimicrobial agents HAMMOND MILTON L (US) 2003-01-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013724-A1 Novel prolines as antimicrobial agents AARS1, EPRS1, TRMT1 PSMB8 1867/4885ADORA1 2185/4885ADORA3 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback